Taken together, these results thus showed that conjugate I could switch the immunosuppressive status to an immune active status in an immunotherapy-resistant pancreatic tumor model, which relied on sustained activation of the cGAS-STING pathway and subsequent full activation of both innate and adaptive immune processes. The gene discussed is CGAS; the disease is pancreatic neoplasm.